Disease breathalyser wins engineering prize
CAMBRIDGE-BASED company Owlstone Medical has been handed the top engineering award by the Royal Academy of Engineering, for its breathalyser and associated breath storage system that could help with early diagnosis of a number of inflammatory and infectious diseases, and cancers.
The company’s under-development “Breath Biopsy” system is able to capture breath samples, analyse them for characteristics associated with diseases or cancer and then store them, which will eventually allow it to build a data bank of breath profiles.
Dr Dame Sue Ion, chairman of the MacRobert Award judging panel, said the breathalyser “is dependable and non-intrusive, and has the potential to revolutionise the way we diagnose and treat a vast array of diseases”.
“The societal benefit is clear to see, and I believe they could realise their vision of saving more than a billion dollars in global healthcare costs and saving hundreds of thousands of lives,” she said.
The system is already in use across more than 100 clinical sites globally.
Owlstone Medical’s Breath Biopsy system has won a major engineering industry award